RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Synergistic Antimicrobial Activity of Bacteriophages and Antibiotics against Staphylococcus aureus

      한글로보기

      https://www.riss.kr/link?id=A104489881

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      This study was designed to assess the synergistic antimicrobial effect of phages combined with antibiotics against Staphylococcus aureus. The phage-antibiotic synergy (PAS) effect was evaluated using the fractional inhibitory concentration (FIC) and f...

      This study was designed to assess the synergistic antimicrobial effect of phages combined with antibiotics against Staphylococcus aureus. The phage-antibiotic synergy (PAS) effect was evaluated using the fractional inhibitory concentration (FIC) and flow cytometric analysis. The determined minimum inhibitory concentration (MIC) values varied from 0.125 to 128 μg/mL for S. aureus KACC 13236 (SAS) and from 0.25 to >256 μg/mL for S. aureus CCARM 3080 (SAR). The PAS effect was more pronounced in SAS treated with phage SA11 in the presence of cefoxitin (FIC=0.62), chloramphenicol (FIC=0.54), and polymyxin B (FIC=0.38). SAS and SAR cells were injured when exposed to asublethal concentration of ciprofloxacin, whereas these cells were highly susceptible to the phage-antibiotic combined treatment, showing 96% of relative percentages of injured and dead cells. The results suggest that the combined treatment of phages and antibiotics can be used to improve antimicrobial efficacy against antibiotic-resistant bacteria.

      더보기

      참고문헌 (Reference)

      1 Yosef I, "Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria" 112 : 7267-7272, 2015

      2 Kirby AE, "Synergistic action of gentamicin and bacteriophage in a continuous culture population of Staphylococcus aureus" 7 : e51017-, 2012

      3 Lowy FD, "Staphylococcus aureus infections" 339 : 520-532, 1998

      4 Comeau AM, "Phage-antibiotic synergy(PAS) : β-Lactam and quinolone antibiotics stimulate virulent phage growth" 2 : e799-, 2007

      5 Knezevic P, "Phage-antibiotic synergism: A possible approach to combatting Pseudomonas aeruginosa" 164 : 55-60, 2013

      6 Vandamme EJ, "Phage therapy and phage control: To be revisited urgently!!" 89 : 329-333, 2014

      7 CLSI, "Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically"

      8 Köck R, "Methicillin-resistant Staphylococcus aureus(MRSA) : Burden of disease and control challenges in Europe" 15 : 1-9, 2010

      9 Kaur S, "Methicillin-Resistant Staphylococcus aureus phage plaque size enhancement using sublethal concentrations of antibiotics" 78 : 8227-8233, 2012

      10 Tice AD, "Meeting the challenges of methicillin-resistant Staphylococcus aureus with outpatient parenteral antimicrobial therapy" 51 : S171-S175, 2010

      1 Yosef I, "Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria" 112 : 7267-7272, 2015

      2 Kirby AE, "Synergistic action of gentamicin and bacteriophage in a continuous culture population of Staphylococcus aureus" 7 : e51017-, 2012

      3 Lowy FD, "Staphylococcus aureus infections" 339 : 520-532, 1998

      4 Comeau AM, "Phage-antibiotic synergy(PAS) : β-Lactam and quinolone antibiotics stimulate virulent phage growth" 2 : e799-, 2007

      5 Knezevic P, "Phage-antibiotic synergism: A possible approach to combatting Pseudomonas aeruginosa" 164 : 55-60, 2013

      6 Vandamme EJ, "Phage therapy and phage control: To be revisited urgently!!" 89 : 329-333, 2014

      7 CLSI, "Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically"

      8 Köck R, "Methicillin-resistant Staphylococcus aureus(MRSA) : Burden of disease and control challenges in Europe" 15 : 1-9, 2010

      9 Kaur S, "Methicillin-Resistant Staphylococcus aureus phage plaque size enhancement using sublethal concentrations of antibiotics" 78 : 8227-8233, 2012

      10 Tice AD, "Meeting the challenges of methicillin-resistant Staphylococcus aureus with outpatient parenteral antimicrobial therapy" 51 : S171-S175, 2010

      11 Qimron U, "Genomewide screens for Escherichia coli genes affecting growth of T7 bacteriophage" 103 : 19039-19044, 2006

      12 Kaźmierczak Z, "Facing antibiotic resistance : Staphylococcus aureus phages as a medical tool" 6 : 2551-2570, 2014

      13 Fischetti VA, "Exploiting what phage have evolved to control gram-positive pathogens" 1 : 188-194, 2011

      14 Chibeu A, "Efficacy of bacteriophage LISTEXTMP100 combined with chemical antimicrobials in reducing Listeria monocytogenes in cooked turkey and roast beef" 167 : 208-214, 2013

      15 Coulter L, "Effect of bacteriophage infection in combination with tobramycin on the emergence of resistance in Escherichia coli and Pseudomonas aeruginosa biofilms" 6 : 3778-3786, 2014

      16 Hirai K, "Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli" 29 : 535-538, 1986

      17 Ayyagari A, "Detection of antimicrobial resistance in common gramnegative and gram-positive bacteria encountered in infectious diseases-an update" 39 : 1-20, 2009

      18 Meletiadis J, "Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumigatus" 54 : 602-609, 2010

      19 Kamal F, "Burkholderia cepacia complex phage-antibiotic synergy (PAS): Antibiotics stimulate lytic phage activity" 81 : 1132-1138, 2015

      20 Burrowes B, "Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens" 9 : 775-785, 2011

      21 Golkar Z, "Bacteriophage therapy: A potential solution for the antibiotic resistance crisis" 8 : 129-236, 2014

      22 Hede K, "Antibiotic resistance : An infectious arms race" 509 : S2-S3, 2014

      23 Penesyan A, "Antibiotic discovery: Combatting bacterial resistance in cells and in biofilm communities" 20 : 5286-5298, 2015

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2010-11-23 학회명변경 영문명 : Korean Society Of Food Science And Biotechnology -> Korean Society of Food Science and Technology KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2001-07-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.75 0.17 0.56
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.49 0.43 0.364 0.06
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼